Multiple drugsDrug resistance and off-label use : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20258-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：387 / 387

相关论文

共 50 条

[21] Multiple drugsVarious toxicities, off-label use and no response to off-label therapy: case report
Reactions Weekly, 2021, 1861 (1) : 232 - 232
[22] Multiple drugsDrug intolerance, lack of efficacy and off label use: case report
Reactions Weekly, 2025, 2057 (1) : 228 - 228
[23] Multiple drugsDrug ineffectiveness in unapproved indication and off label use: case report
Reactions Weekly, 2023, 1982 (1) : 263 - 263
[24] Multiple drugsAcquired resistance, various toxicities following off-label use: case report
Reactions Weekly, 2021, 1854 (1) : 237 - 237
[25] Inotuzumab ozogamicinDevelopment of resistance and off-label use: case report
Reactions Weekly, 2019, 1783 (1) : 147 - 147
[26] DalbavancinDrug-resistance and off-label use: case report
Reactions Weekly, 2019, 1734 (1) : 170 - 170
[27] Ixazomib/venetoclaxDrug resistance and off-label use: case report
Reactions Weekly, 2022, 1927 (1) : 308 - 308
[28] Azacitidine/olaparibDrug resistance and off-label use: case report
Reactions Weekly, 2022, 1904 (1) : 92 - 92
[29] Multiple drugsDrugs ineffective and off-label use: case report
Reactions Weekly, 2022, 1904 (1) : 305 - 305
[30] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1975 (1) : 255 - 255

← 1 2 3 4 5 →